Concept paper on the Development of a CPMP Points to consider on the need for reproduction toxicity studies in the development of human insulin analogues
Revised Version of Annex 14 — Manufacture of medicinal products derived from human blood or plasma to the EU Guide to Good Manufacturing Practice Finalisée en février 2000